Pharmacy

04/03/2014 - 8:55am

MannKind Corp. on Tuesday announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration voted 13-to-1 to recommend that Afrezza (insulin human [rDNA origin]) inhalation powder be granted marketing approval by the FDA to improve glycemic control in adults with Type 1 diabetes and voted 14-to-0 to recommend that Afrezza be granted marketing approval by the FDA to improve glycemic control in adults with Type 2 diabetes.

04/03/2014 - 8:25am

McKesson on Thursday announced that it ranked No. 8 on this year’s InformationWeek Elite 100.

04/03/2014 - 7:31am

In an effort to prevent prescription drug abuse, and in collaboration with Informed Families/The Florida Family Partnership, all 622 Publix pharmacy stores in Florida are promoting the Lock Your Meds campaign in April 2014, the supermarket chain announced Tuesday.

04/03/2014 - 6:58am

Axium Healthcare Pharmacy announced that it will begin to dispense Otezla, the new oral therapy for the treatment of adults with active psoriatic arthritis.

04/02/2014 - 1:38pm

Publix and Walgreens have partnered with a local coalition to collect expired medications, according to a report in the Delray Beach newspaper the Pineapple published Monday.

04/02/2014 - 11:29am

Greer Labs, a developer and provider of allergy immunotherapy products and services, announced that the Food and Drug Administration has approved Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablet.

04/02/2014 - 11:28am

Sandoz on Tuesday announced the U.S. market introduction of its calcipotriene and betamethasone dipropionate ointment, the first generic version of Leo Pharma’s Taclonex Ointment.

04/02/2014 - 9:40am

Symphony Health Solutions on Wednesday released research on the affects of the Affordable Care Act on Medicaid drug spending.

04/01/2014 - 11:57am

Teva Pharmaceuticals on Tuesday announced the introduction and availability of Raloxifene hydrochloride tablets, USP.

04/01/2014 - 11:08am

Sanofi on Monday named Anne Beal to the newly created position of chief patient officer.